Abstract:Background Photodynamic therapy (PDT) induced lipid peroxidation reaction can lead to necrosis and apoptosis of extrahepatic cholangiocarcinoma (ECC) cells, reducing the tumor load. However, the depth of action of PDT is shallow, and its therapy efficacy is weak, making it difficult to achieve eradication even with multiple treatments. Objectives This study aims to investigate the mechanism and main pathways of ferroptosis in cholangiocarcinoma under Hematoporphyrin‐mediated photodynamic therapy, and to compare the effects of different ferroptosis inducers on photodynamic therapy‐induced ferroptosis in cholangiocarcinoma. To provide an experimental basis for selecting appropriate ferroptosis‐inducing agents and synergizing with photodynamic therapy during the clinical perioperative period. Methods The Cell Counting Kit‐8 (CCK‐8) was used to examine the cytotoxicity of cholangiocarcinoma cells following PDT. Flow cytometry was used to detect apoptotic cell percentage and cell cycle changes to assess the enhanced photodynamic production of reactive oxygen species (ROS) by different ferroptosis inducers, confocal imaging was used to de‐assay ROS content. Western blot analysis was employed to detect the expression of GPX4 、FSP1、ASCL4 and SLC7A11. Furthermore, a fluorescence spectrophotometric assay was used to quantify the alterations in lipid peroxides (MDA, LPO, GSH, and Fe2+). Results The combination of PDT with Lenvatinib or Erastin resulted in increased ROS levels, and decreased GSH content, tumor cells were inhibited in the G2 phase, and the proportion of apoptotic cells increased. Additionally, GPX4, FSP1, and SLC7A11 protein expression decreased, whereas ASCL4 increased This was accompanied by heightened levels of Fe2+, LPO, and MDA. Induction of the ferroptosis pathway was observed to enhance the therapeutic efficacy of PDT. Conclusion Our findings suggest that Erastin or Lenvatinib can enhance the induction of ferroptosis in cholangiocarcinoma cells by photodynamic therapy by increasing intracellular ROS and inhibiting intracellular antioxidant pathways.

The Chemosensitizer Ferulic Acid Enhances Epirubicin-Induced Apoptosis in MDA-MB-231 Cells

Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells Can Be Protected Against by KLF4-Mediated Upregulation of Xct.

Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway

Synergistic Photochemo Effects Based on Light-Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy

Mechano‐Responsive Leapfrog Micelles Enable Interactive Apoptotic and Ferroptotic Cancer Therapy

Asymmetric silicon phthalocyanine based nanoparticle with spatiotemporally targeting of mitochondria for synergistic apoptosis-ferroptosis antitumor treatment

Biomimetic photosensitizer nanocrystals trigger enhanced ferroptosis for improving cancer treatment

Study on the Synergistic Mechanism of Photodynamic Therapy Combined With Ferroptosis Inducer to Induce Ferroptosis in Cholangiocarcinoma

Data on cell cycle in breast cancer cell line, MDA-MB-231 with ferulic acid treatment

Photothermal Enhanced Polyphenol-Based Nanofibers Ameliorate Catalytic Efficiency of Ferroptosis for Synergistic Tumor Therapy

Synergistic ferroptosis in triple-negative breast cancer cells: Paclitaxel in combination with Erastin induced oxidative stress and Ferroportin-1 modulation in MDA-MB-231 cells

Engineering a Ph/glutathione-Responsive Tea Polyphenol Nanodevice As an Apoptosis/Ferroptosis-Inducing Agent.

Ferulic Acid Induces Autophagy and Apoptosis in Colon Cancer CT26 Cells via the MAPK Pathway

Fe2+/Fe3+ Ions Chelated with Ultrasmall Polydopamine Nanoparticles Induce Ferroptosis for Cancer Therapy.

Enhancement Of Chemotherapeutic Agent-Induced Apoptosis By Inhibition Of Nf-Kappa B Using Ursolic Acid

Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer

Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis

Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells

Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy

Epigallocatechin-3-gallate Enhances ER Stress-Induced Cancer Cell Apoptosis by Directly Targeting PARP16 Activity

A Ferroptosis‐Inducing Arsenene‐Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer